Real-world acne treatment adherence spans 6% to 84%, with cost, adverse effects, and slow results driving nonadherence.
A value-based care pilot within Kentucky’s Medicaid program reduced total costs for adults with substance use disorder while ...
Senator Andy Kim (D, New Jersey) discusses the response to a Senate speech on caregiving and disagreements over how to ...
Pooled real-world data show an 88% response rate with brexu-cel in relapsed mantle cell lymphoma (MCL), but cost and QOL data ...
Florin Draica, MD, MBA, of Shionogi outlines how clinicians and pharmacies can expand access to ensitrelvir postexposure ...
High efficacy has no single definition, and a large toolbox means little when formularies limit access. The panel describes ...
Employer diabetes guide; Camden psychedelic therapy input; CRC after EMR; rural HFrEF care; JAMA obesity report.
In a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated ...
Faculty say heart failure patients miss iron deficiency care when no one owns it; pharmacist-led workflows may help close the ...
Pimicotinib, a once-daily oral CSF-1R inhibitor, is now FDA approved for adults with TGCT for whom surgery may worsen ...
Research at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 ...
Obinutuzumab (Gazyva) led to complete remission of proteinuria in more patients than tacrolimus did, according to the FDA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results